Advertisement

The Comorbidity of Back and Cervical Pain, Anxiety, Depression and Alexitymia

  • Radiy EsinEmail author
  • Elena Gorobets
  • Oleg Esin
  • Ilshat Khayrullin
  • Victor Gorobets
  • Yulia Volskaya
Article
  • 7 Downloads

Abstract

Patients with alexithymia have difficulties in verbal description of their sensations. The reasons of this specific cognitive modality have not been explained entirely yet, so there is an urge to use psychometric instruments to analyze this peculiarity and to measure alexithymia simultaneously with other parameters (in neurology, different types of pain, anxiety, depression, dizziness). The aim of the study was to identify the presence or absence of statistically significant correlation between nonspecific cervical and back pain, anxiety, depression, and alexithymia. The authors observed 435 patients with cervical and back pain complaints. After neurological examination, there were revealed 156 patients aged 18–50 years (average age 38.2 ± 10.1 years, 89 females and 67 males) with nonspecific cervical and back pain. All patients passed through the Russian language version of the 20-point Toronto alexithymia scale (TAS-20) and were divided into three groups: high level of alexithymia (group A), border zone (group B), and low level of alexithymia (group C). The patients were also divided into 2 subgroups: acute pain and chronic pain. All patients passed through the assessment of pain severity, disability index, satisfaction with life index (according to VAS scale), and anxiety and depression (according to Hospital Anxiety and Depression Scale (HADS)). Statistical assessment included the Shapiro–Wilk test for determining the type of data distribution, methods of descriptive statistics with the presentation of data in the form of an average value and standard deviation, and contingency table method for comparing the studied groups. The critical level of significance (p) in testing statistical hypotheses in the study was taken 0.05. Processing of the obtained data showed that patients with high level of alexithymia had statistically significant higher rates of pain severity, disability index, and level of anxiety and depression, and significantly lower satisfaction with life index than patients with border and low levels of alexithymia. The results also show that the concrete type on nonspecific pain (acute or chronic) is not connected with the risk of comorbidity with anxiety, depression, and alexithymia. Thus, in clinical practice, it is advisable to test patients with pain complaints also presenting tools to identify the level of anxiety and alexithymia.

Keywords

Alexithymia Pain Anxiety Depression HADS TAS-20 Disability index Satisfaction with life index Comorbidity VAS 

Notes

Funding Information

The reported study was funded by the Russian Foundation for Basic Research (RFBR) according to the research project no. 17-04-00575 (for Elena Gorobets, Radiy Esin, Oleg Esin) and supported by the program of competitive growth of Kazan Federal University (for Victor Gorobets, Ilshat Khayrullin, Yulia Volskaya).

Compliance with Ethical Standards

Conflict of Interests

None.

Research Involving Human Participants or Animals

None.

Informed Consent

None.

References

  1. 1.
    Yao, Z., Xuan, Y., & Zhu, X. (2019). Effect of experience information on emotional word processing in alexithymia. Journal of Affective Disorders, 259, 251–258.CrossRefGoogle Scholar
  2. 2.
    Sifneos, P. E. (1973). The prevalence of “alexithymic” characteristics in psychosomatic patients. Psychotherapy and Psychosomatics, 22, 255–262.CrossRefGoogle Scholar
  3. 3.
    Goerlich, K. S. (2018). The multifaceted nature of alexithymia–A neuroscientific perspective. Frontiers in Psychology, 9, 1614.CrossRefGoogle Scholar
  4. 4.
    Nyklíček, I., & Vingerhoets, A. J. J. M. (2000). Alexithymia is associated with low tolerance to experimental painful stimulation. Pain, 85(3), 471–475.CrossRefGoogle Scholar
  5. 5.
    Girard, M., Labrunie, A., Marin, B., & Malauzat, D. (2015). Experimental pain sensitivity in subjects with major depression: Many pain complaints without hypersensitivity. International Journal of Psychiatry in Medicine, 50(2), 219–237.CrossRefGoogle Scholar
  6. 6.
    Franz, M., Popp, K., Schaefer, R., et al. (2008). Alexithymia in the German general population. Social Psychiatry and Psychiatric Epidemiology, 43, 54–62.CrossRefGoogle Scholar
  7. 7.
    Mattila, A. K., Salminen, J. K., Nummi, T., & Joukamaa, M. (2006). Age is strongly associated with alexithymia in the general population. Journal of Psychosomatic Research, 61, 629–635.CrossRefGoogle Scholar
  8. 8.
    Aaron, R. V., Fisher, E. A., de la Vega, R., Lumley, M. A., & Palermo, T. M. (2019). Alexithymia in individuals with chronic pain and its relation to pain intensity, physical interference, depression, and anxiety: A systematic review and meta-analysis. Pain, 160(5), 994–1006.CrossRefGoogle Scholar
  9. 9.
    Kindler, S., Schwahn, C., Terock, J., Mksoud, M., et al. (2019). Alexithymia and temporomandibular joint and facial pain in the general population. Journal of Oral Rehabilitation, 46(4), 310–320.Google Scholar
  10. 10.
    Marchi, L., Marzetti, F., Orru, G., Lemmetti, S., Miccoli, M., & Ciacchini, R. (2019). Alexithymia and psychological distress in patients with fibromyalgia and rheumatic disease. Frontiers in Psychology, 10, 1735.CrossRefGoogle Scholar
  11. 11.
    Pecukonis, E. V. (2009). Physical self-efficacy and alexithymia in women with chronic intractable back pain. Pain Management Nursing, 10, 116–123.CrossRefGoogle Scholar
  12. 12.
    Esin, O., Gorobets, E., Khairullin, I., & Esin, R. (2017). Alexithymia as a predictor of chronic tension headaches. BioNanoScience, 7(2), 272–275.CrossRefGoogle Scholar
  13. 13.
    Esin, R., Gorobets, E., Esin, O., Khayrullin, I. K., Sakhapova, L., & Martyanov, D. (2018). Alexithymia as a predictor of worse prognosis in postural phobic vertigo. Bionanoscience, 8(1), 373–378.CrossRefGoogle Scholar
  14. 14.
    Shibata, M., Ninomiya, T., Jensen, M. P., et al. (2014). Alexithymia is associated with greater risk of chronic pain and negative affect and with lower life satisfaction in a general population: The Hisayama study. PLoS One, 9(3), e90984.CrossRefGoogle Scholar
  15. 15.
    Frießem, C. H., Willweber-Strumpf, A., & Zenz, M. W. (2009). Chronic pain in primary care. German figures from 1991 and 2006. BMC Public Health, 9, 299.CrossRefGoogle Scholar
  16. 16.
    Breivik, H., Collett, B., Ventafridda, V., et al. (2006). Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. European Journal of Pain, 10, 287.CrossRefGoogle Scholar
  17. 17.
    Nahin, R. L. (2015). Estimates of pain prevalence and severity in adults: United States, 2012. The Journal of Pain, 16(8), 769–780.CrossRefGoogle Scholar
  18. 18.
    Mills, S., Torrance, N., & Smith, B. H. (2016). Identification and management of chronic pain in primary care: A review. Current Psychiatry Reports, 18, 22.CrossRefGoogle Scholar
  19. 19.
    Esin, R., Gorobets, E., Galiullin, K., & Esin, O. (2014). Alexithymia – Baseline trends of research. Z nevrol psikhiatr im SS Korsakova, 114(12), 148–151.CrossRefGoogle Scholar
  20. 20.
    Treede, R. D., Rief, W., Barke, A., & Aziz, Q. (2015). A classification of chronic pain for ICD-11. Pain, 156(6), 1003–1007.Google Scholar
  21. 21.
    Boonstra, A. M., Schiphorst Preuper, H. R., Reneman, M. F., et al. (2008). Reliability and validity of the visual analogue scale for disability in patients with chronic musculoskeletal pain. International Journal of Rehabilitation Research, 31, 165–169.CrossRefGoogle Scholar
  22. 22.
    Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.CrossRefGoogle Scholar
  23. 23.
    Gorobets, E., Esin, O., Esin, R., Martyanov, D., & Galiullin, K. (2018). Pain, anxiety and depression scales and questionnaires for patients with low and high levels of alexithymia // 5th International Multidisciplinary Scientific Conferences on Social Sciences & Arts SGEM 2018, SGEM2018 Conference Proceedings. 5: 263–271.Google Scholar
  24. 24.
    Starostina, E. G., Taylor, G. D., Quilty, L. K., Bobrov, A. E., Moshnyaga, E. N., Puzyreva, N. V., Bobrova, M. A., Ivashkin, M. G., Krivchikova, M. N., Shavrikova, E. P., & Bagby, R. M. (2010). Toronto scale of alexithymia (20 points): Validation of the Russian version on a sample of therapeutic patients. Social and Clinical Psychiatry, 20(4), 31–38.Google Scholar
  25. 25.
    Wolfe, F., Clauw, D. J., Fitzcharles, M.-A. L., et al. (2016). Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Seminars in Arthritis and Rheumatism, 46(3), 319–329.CrossRefGoogle Scholar
  26. 26.
    Arnold, L. M., Bennett, M. R., Crofford, L. J., Dean, L. E., et al. (2019). AAPT diagnostic criteria for fibromyalgia. The Journal of Pain, 20(6), 611–628.CrossRefGoogle Scholar
  27. 27.
    Kano, M., & Fukudo, S. (2013). The alexithymic brain: The neural pathways linking alexithymia to physical disorders. Biopsychosocial Medicine, 7(1), 1.CrossRefGoogle Scholar
  28. 28.
    Mico, J. A., Ardid, D., Berrocoso, E., & Eschalier, A. (2006). Antidepressants and pain. Trends in Pharmacological Sciences, 27, 348–354.CrossRefGoogle Scholar
  29. 29.
    Pahlevan, M., Besharat, M. A., Borjali, A., & Farahani, H. (2019). A hypothetical model of pain perception in patients with chronic pain: The predictive role of unconscious, emotional, behavioral and meta-cognitive factors. Annales Médico-Psychologiques, 177(9), 875–883.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2020

Authors and Affiliations

  1. 1.Laboratory of Clinical LinguisticsKazan Federal UniversityKazanRussia
  2. 2.Department of Applied and Experimental LinguisticsKazan Federal UniversityKazanRussia
  3. 3.Department of NeurologyKazan State Medical AcademyKazanRussia
  4. 4.Institute of Fundamental Medicine and BiologyKazan Federal UniversityKazanRussia

Personalised recommendations